chr22-30613131-T-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The NM_000355.4(TCN2):c.427+89T>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.222 in 1,535,186 control chromosomes in the GnomAD database, including 38,586 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.22   (  3657   hom.,  cov: 32) 
 Exomes 𝑓:  0.22   (  34929   hom.  ) 
Consequence
 TCN2
NM_000355.4 intron
NM_000355.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  0.368  
Publications
4 publications found 
Genes affected
 TCN2  (HGNC:11653):  (transcobalamin 2) This gene encodes a member of the vitamin B12-binding protein family. This family of proteins, alternatively referred to as R binders, is expressed in various tissues and secretions. This plasma protein binds cobalamin and mediates the transport of cobalamin into cells. This protein and other mammalian cobalamin-binding proteins, such as transcobalamin I and gastric intrisic factor, may have evolved by duplication of a common ancestral gene. Alternative splicing results in multiple transcript variants.[provided by RefSeq, May 2010] 
TCN2 Gene-Disease associations (from GenCC):
- transcobalamin II deficiencyInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet
 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BP6
Variant 22-30613131-T-A is Benign according to our data. Variant chr22-30613131-T-A is described in ClinVar as Benign. ClinVar VariationId is 1179882.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.228  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes   AF:  0.219  AC: 33276AN: 151936Hom.:  3651  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
33276
AN: 
151936
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD4 exome  AF:  0.223  AC: 307930AN: 1383132Hom.:  34929   AF XY:  0.223  AC XY: 152657AN XY: 683938 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
307930
AN: 
1383132
Hom.: 
 AF XY: 
AC XY: 
152657
AN XY: 
683938
show subpopulations 
African (AFR) 
 AF: 
AC: 
6143
AN: 
31464
American (AMR) 
 AF: 
AC: 
7615
AN: 
36218
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
4980
AN: 
25042
East Asian (EAS) 
 AF: 
AC: 
7071
AN: 
35946
South Asian (SAS) 
 AF: 
AC: 
16384
AN: 
79106
European-Finnish (FIN) 
 AF: 
AC: 
12790
AN: 
45752
Middle Eastern (MID) 
 AF: 
AC: 
1359
AN: 
4900
European-Non Finnish (NFE) 
 AF: 
AC: 
238937
AN: 
1067266
Other (OTH) 
 AF: 
AC: 
12651
AN: 
57438
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 12301 
 24601 
 36902 
 49202 
 61503 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 8160 
 16320 
 24480 
 32640 
 40800 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome   AF:  0.219  AC: 33288AN: 152054Hom.:  3657  Cov.: 32 AF XY:  0.219  AC XY: 16271AN XY: 74334 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
33288
AN: 
152054
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
16271
AN XY: 
74334
show subpopulations 
African (AFR) 
 AF: 
AC: 
7993
AN: 
41460
American (AMR) 
 AF: 
AC: 
3159
AN: 
15264
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
715
AN: 
3468
East Asian (EAS) 
 AF: 
AC: 
1001
AN: 
5166
South Asian (SAS) 
 AF: 
AC: 
1010
AN: 
4818
European-Finnish (FIN) 
 AF: 
AC: 
2974
AN: 
10598
Middle Eastern (MID) 
 AF: 
AC: 
72
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
15708
AN: 
67966
Other (OTH) 
 AF: 
AC: 
462
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.499 
Heterozygous variant carriers
 0 
 1341 
 2683 
 4024 
 5366 
 6707 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 352 
 704 
 1056 
 1408 
 1760 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
834
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:2 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not provided    Benign:2 
Jul 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.